Tuesday, December 22, 2009

Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia

This study is currently recruiting participants.
Verified by Penwest Pharmaceuticals Co., December 2009
First Received: December 17, 2009   Last Updated: December 18, 2009   History of Changes
Sponsor:
Penwest Pharmaceuticals Co.
Information provided by:
Penwest Pharmaceuticals Co.
ClinicalTrials.gov Identifier:
NCT01035671



Condition Intervention Phase
Friedreich's Ataxia
Drug: alpha-tocopherolquinone (A0001)
Drug: placebo
Phase II

No comments:

Post a Comment